Collagen XXII, a novel human collagen and uses thereof
AssigneeThe General Hospital Corporation
InventorsRobert Eugene Burgeson, Manuel Koch, Douglas R. Keene, William Joseph Brunken, Leena Bruckner-Tuderman
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe General Hospital Corporation
InventorsRobert Eugene Burgeson, Manuel Koch, Douglas R. Keene, William Joseph Brunken, Leena Bruckner-Tuderman
Estimating the term…
The invention provides isolated nucleic acids molecules, designated collagen XXII nucleic acid molecules, which encode a novel collagen. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing collagen XXII nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a collagen XXII gene has been introduced or disrupted. The invention still further provides isolated collagen XXII proteins, fusion proteins, antigenic-peptides and anti-collagen XXII antibodies. Diagnostic methods utilizing compositions of the invention are also provided.
An isolated polypeptide comprising an amino acid sequence at least 80% identical to the amino acid sequence of SEQ ID NO:2.
An isolated polypeptide comprising an amino acid sequence at least 95% identical to a sequence selected from the group consisting of:
An antigenic fragment of SEQ ID NO:2, wherein the fragment comprises at least eight consecutive amino acid residues of SEQ ID NO:2.
Dependencies are inferred from the claim text.